NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Motilal Oswal Reiterates Buy Rating for CEAT

CEAT's fourth quarter (4QFY26) adjusted Profit After Tax (PAT) was significantly higher than the estimates of Motilal Oswal's research team, at INR2.5 billion. This notable increase is primarily attributed to higher other income, despite the operational performance aligning with the research team's expectations. The recent reduction in Goods and Services Tax (GST) rates has contributed to a surge in tyre demand, both in replacement and Original Equipment Manufacturer (OEM) segments.

However, the recent spike in input costs is expected to exert near-term pressure on CEAT's margins. The industry will require a couple of quarters to fully pass on the impact of these increased costs. Additionally, while the Camso acquisition is expected to take time to normalize, Motilal Oswal remains optimistic about the long-term benefits this acquisition can bring to the group.

IndicatorCEAT (4QFY26)Motilal Oswal Estimate
Adjusted PAT (INR billion)2.52.0
GST RateReducedN/A
Tyre Demand GrowthIncreasedN/A

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Motilal Oswal's research team has reaffirmed its BUY rating for CEAT, with a Target Price (TP) of INR4,228. This valuation is based on an estimated price-to-earnings ratio of ~18 times the expected earnings per share (EPS) for fiscal year 2028 (FY28E). The research team's positive outlook for CEAT is driven by the long-term benefits expected from the Camso acquisition.

Investor Takeaway

Investors should consider buying CEAT stock with a target price of Rs 4,228.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.